In accord with a function in promoting tumor progression, TMPRSS2-ERG translocations are observed in a significantly lower fraction of high-grade prostate intraepithelial neoplasias, a non-invasive precursor stage, than in invasive carcinomas [21]. This evidence concerns the gene ERG and invasive carcinoma.